Company: BDRX
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001214659-25-006756
Chunk: 142

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-01
Form: DRS
Chunk 142
---
 in part. |

We have been advised
by the that it intends to make a market in our Depositary Shares
but that it is not obligated to do so and may discontinue making a market at any time without notice. In connection with this offering,
the underwriter may distribute prospectuses electronically.

Option to Purchase Additional Securities

We have granted
the underwriter an option exercisable within 45 days of the date of this prospectus to purchase from us up to additional
Depositary Shares at a price of $ per share or up to Pre-Funded Warrants
at a purchase price of $ per Pre-Funded Warrant and/or up to Series L Warrants
at a purchase price of $0.0001 per Series L Warrant, less the underwriting discounts and commissions to cover over-allotments, if any.

Underwriting Discount

Units sold by the
underwriter to the public will initially be offered at the initial offering price set forth on the cover of this prospectus. Any units
sold by the underwriter to securities dealers may be sold at a discount of up to $ per Unit from the
public offering price. The underwriter may offer the units through one or more of its affiliates or selling agents. If all the units are
not sold at the public offering price, the underwriter may change the offering price and the other selling terms. Upon execution of the
underwriting agreement, the underwriter will be obligated to purchase the units at the prices and upon the terms stated therein.

The following table
shows the per share and total underwriting discount we will pay to the underwriter assuming both no exercise and full exercise of the
underwriter’s option to purchase from us up to additional Depositary Shares at a price of $ per
share or up to Pre-Funded Warrants at a purchase price of $ per Pre-Funded
Warrant and/or up to Series L Warrants at a purchase price $ per Series L Warrant,
less the underwriting discounts and commissions to cover over-allotments, if any.

|                                                                         |     | Per Unit(1) |     | Per Pre-Funded Unit (2) |     | Total     
 Without   
 Over-     
 Allotment |     | Total With 
 Full Over- 
 Allotment  |
|:------------------------------------------------------------------------|:----|:------------|:----|:------------------------|:----|:----------|:----|:-----------|
| Public offering price                                                   |     | $           |     | $                       |